ImmunityBio Inc
NASDAQ:IBRX
Market Cap (Intraday) | 2.31B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $3.78 |
50-Day MA | $5.04 |
200-Day MA | $5.23 |
ImmunityBio Inc Stock, NASDAQ:IBRX
3530 John Hopkins Court, San Diego, California 92121
United States of America
Phone: +1.844.696.5235
Number of Employees: 628
Description
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.